Search - tctmd.com

Displaying 781 - 800 of 1141

Sort: Relevancy | Date

News Industry News

Cardiome Submits Supplemental New Drug Submission (sNDS) For AGGRASTAT To Health Canada

July 22, 2015

Identifying Risk Beyond Stenosis in the ED Lessons Learned from ROMICAT

Presentation SCCT 2015

Identifying Risk Beyond Stenosis in the ED Lessons Learned from ROMICAT

Presenter: Maros Ferencik

July 18, 2015

News Industry News

Hospira Announces U.S. Launch of Generic Bivalirudin for Injection

July 16, 2015

News Daily News

肺栓塞发作后，二级抗凝效果未持续

July 13, 2015

News Industry News

NICE recommends once-daily LIXIANA® (edoxaban) for the treatment and prevention of recurrent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in adults

July 13, 2015

News Daily News

Después de Sufrir un Embolismo Pulmonar el Beneficio de la Anticoagulación Secundaria No se Mantiene

July 13, 2015

News Daily News

After Pulmonary Embolism, Benefit of Secondary Anticoagulation Does Not Persist

July 13, 2015

6 Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism

Presentation

6 Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism

Presenter: Francis Couturaud

July 10, 2015

News Industry News

UK launch for Daiichi's bloodthinner Lixiana

July 10, 2015

News Industry News

The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin)

July 09, 2015

News Daily News

La Aprobación de la FDA de Cangrelor Amplía las Opciones Antiplaquetarias para la PCI

June 29, 2015

News Daily News

FDA 批准坎格雷洛作为 PCI 的抗血小板治疗方案

June 29, 2015

News Daily News

FDA Approval of Cangrelor Expands Antiplatelet Options for PCI

June 29, 2015

News Daily News

RE-VERSE AD: El Antídoto de Dabigatran, Seguro y Eficaz en un Análisis Provisional

June 25, 2015

News Daily News

RE-VERSE AD: Dabigatran Antidote Appears Safe, Effective in Interim Analysis

June 25, 2015

News Daily News

RE-VERSE AD：中期分析表明达比加群中和剂似乎安全有效

June 25, 2015

News Industry News

Portola Pharmaceuticals Announces In Vivo Study Results Demonstrating Andexanet Alfa Significantly Reduced Bleeding and Reversed Anticoagulation Activity of Rivaroxaban While Four-Factor Prothrombin C

June 25, 2015

News Daily News

En Análisis ACCOAST Identifica los Factores asociados a Más Riesgos Hemorrágicos en el Manejo de Cuadros de SCASEST

June 22, 2015

News Daily News

ACCOAST分析发现了NSTE-ACS患者更高出血风险的有关因素

June 22, 2015

News Daily News

ACCOAST Analysis Identifies Factors Tied to Higher Bleeding Risks in NSTE-ACS

June 22, 2015

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.